Literature DB >> 26802154

HER2 imaging in the ZEPHIR study.

A S Clark1, A DeMichele2, D Mankoff3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26802154     DOI: 10.1093/annonc/mdw033

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

1.  Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study.

Authors:  Joanne E Mortimer; James R Bading; Paul H Frankel; Mary I Carroll; Yuan Yuan; Jinha M Park; Lusine Tumyan; Nikita Gidwaney; Erasmus K Poku; John E Shively; David M Colcher
Journal:  J Nucl Med       Date:  2021-12-02       Impact factor: 11.082

Review 2.  Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture.

Authors:  Clément Bailly; Caroline Bodet-Milin; Mickaël Bourgeois; Sébastien Gouard; Catherine Ansquer; Matthieu Barbaud; Jean-Charles Sébille; Michel Chérel; Françoise Kraeber-Bodéré; Thomas Carlier
Journal:  Cancers (Basel)       Date:  2019-08-31       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.